Search

everythinglearnresearchcommunity

for

Search:↓

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

The non-cross-linked hyaluronic acid compound effectively and safely improves keratosis pilaris.

The oral supplement with Pinus pinaster and Grape seed extract, used with sunscreen, effectively and safely improved mild-to-moderate facial melasma.

High retinol intake may worsen hair loss in alopecia areata.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Combining antihistamines with topical treatment improves hair regrowth in alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

Actinic keratosis is more common in older men with certain genetic traits, but smoking seems to reduce its odds.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Topical metformin effectively treats melasma with minimal side effects.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

PRP is an effective and safe treatment for hair loss in women.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Bimatoprost may help treat hair loss from alopecia areata.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.